Literature DB >> 349901

[Metabolic studies under administration of oral contraceptives. A review].

S Hauschildt.   

Abstract

The use of oral contraceptives can produce changes in the metabolism of carbohydrates, lipids, proteins, vitamins, and minerals. Responsible for the alterations seems to be the used oestrogen- and gestagen derivative and not so much the type of the contraceptive. The most frequent findings are raised serum-glucose-, insulin-, and triglyceride levels; disturbances in protein-metabolism increase the risk of developing thrombosis and hypertonia. Little is known about the significance of oral contraceptives on the vitamin- and mineral metabolism--yet extreme deficiencies have not been observed so far. Oral contraceptives can become an extra risk factor when given to women with metabolic disturbances.

Entities:  

Keywords:  Ascorbic Acid; Biology; Carbohydrate Metabolic Effects; Glucose Metabolism Effects; Hematological Effects; Hemic System; Lipid Metabolic Effects; Lipids; Metabolic Effects; Oral Contraceptives; Physiology; Plasma Protein Binding Capacity; Serum Copper Level; Serum Iron Level; Serum Zinc Level; Tryptophan Metabolism Alterations; Vitamin A; Vitamin B Complex

Mesh:

Substances:

Year:  1978        PMID: 349901     DOI: 10.1007/bf02020687

Source DB:  PubMed          Journal:  Z Ernahrungswiss        ISSN: 0044-264X


  126 in total

Review 1.  Alterations of lipid metabolism by contraceptive steroids.

Authors:  P Beck
Journal:  J Steroid Biochem       Date:  1975-06       Impact factor: 4.292

2.  Gonadal steroid effects on plasma lipoproteins and individual phospholipids.

Authors:  A Gustafson; A Svanborg
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

3.  Quantitative changes in plasma amino acids induced by oral contraceptives.

Authors:  I L Craft; T J Peters
Journal:  Clin Sci       Date:  1971-10       Impact factor: 6.124

4.  Comparison of the mechanisms underlying carbohydrate intolerance in subclinical diabetic women during pregnancy and during post-partum oral contraceptive steroid treatment.

Authors:  P Beck; S A Wells
Journal:  J Clin Endocrinol Metab       Date:  1969-06       Impact factor: 5.958

5.  Decreased serum B 12 levels with oral contraceptive use.

Authors:  L F Wertalik; E N Metz; A F LoBuglio; S P Balcerzak
Journal:  JAMA       Date:  1972-09-18       Impact factor: 56.272

6.  Immunochemical quantitation of human transferrin in pregnancy and during the administration of oral contraceptives.

Authors:  J M Jacobi; L W Powell; T J Gaffney
Journal:  Br J Haematol       Date:  1969-11       Impact factor: 6.998

7.  Serum copper and zinc levels in patients taking oral contraceptives.

Authors:  J G Schenker; S Hellerstein; E Jungreis; W Z Polishuk
Journal:  Fertil Steril       Date:  1971-04       Impact factor: 7.329

8.  Alterations in carbohydrate metabolism induced by progesterone in cases of endometrial carcinoma and hyperplasia.

Authors:  F Benjamin; D J Casper
Journal:  Am J Obstet Gynecol       Date:  1966-04-01       Impact factor: 8.661

9.  The effect of some ovulation inhibitors on the lipid metabolism. Preliminary report.

Authors:  S Brody; A M Högdahl; L Nilsson; A Svanborg; O Vikrot
Journal:  Acta Med Scand       Date:  1966-04

10.  Vitamin A, pregnancy, and oral contraceptives.

Authors:  J Wild; C J Schorah; R W Smithells
Journal:  Br Med J       Date:  1974-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.